These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Sulphasalazine in the treatment of juvenile rheumatoid arthritis: a preliminary open trial.
    Author: Ozdogan H, Turunç M, Deringöl B, Yurdakul S, Yazici H.
    Journal: J Rheumatol; 1986 Feb; 13(1):124-5. PubMed ID: 2871188.
    Abstract:
    Sulphasalazine was administered to 18 patients with juvenile rheumatoid arthritis (JRA). The mean duration of therapy was 7.8 +/- 2.6 months. There was significant improvement in all clinical variables and erythrocyte sedimentation rate. Five children developed minor and transient side effects. Medication was discontinued in 3 patients: one because of leukopenia, 2 for lack of effect. These results suggest that sulphasalazine is an effective and relatively safe drug which may prove to be a useful second line agent in the management of JRA.
    [Abstract] [Full Text] [Related] [New Search]